Long interspersed nuclear element-1 hypomethylation and oxidative stress: Correlation and bladder cancer diagnostic potential

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Patchsung, Maturada ^a   Boonla, Chanchai ^a   Amnattrakul, Passakorn ^a   Dissayabutra, Thasinas ^a   Mutirangura, Apiwat ^a   Tosukhowong, Piyaratana ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT;

ADULT; AGED; ARTICLE; BLADDER CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA METHYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG INTERSPERSED NUCLEAR ELEMENT 1; LONG INTERSPERSED REPEAT; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BLADDER TUMOR; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROTEIN CARBONYLATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; DNA METHYLATION; FEMALE; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEIN CARBONYLATION; URINARY BLADDER NEOPLASMS;

EID: 84866493708     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037009     Document Type: Article

References (48)

1. Kawai K, Yamamoto M, Kameyama S, Kawamata H, Rademaker A, et al. (1993) Enhancement of rat urinary bladder tumorigenesis by lipopolysaccharide-induced inflammation. Cancer Res 53: 5172–5175.
2. Michaud DS (2007) Chronic inflammation and bladder cancer. Urol Oncol 25: 260–268.
3. Opanuraks J, Boonla C, Saelim C, Kittikowit W, Sumpatanukul P, et al. (2010) Elevated urinary total sialic acid and increased oxidative stress in patients with bladder cancer. Asian Biomedicine 4: 703–710.
4. Akcay T, Saygili I, Andican G, Yalcin V (2003) Increased formation of 8-hydroxy-29-deoxyguanosine in peripheral blood leukocytes in bladder cancer. Urol Int 71: 271–274.
5. Salim EI, Morimura K, Menesi A, El-Lity M, Fukushima S, et al. (2008) Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int J Cancer 123: 601–608.
6. Soini Y, Haapasaari KM, Vaarala MH, Turpeenniemi-Hujanen T, Karja V, et al. (2011) 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma. Int J Clin Exp Pathol 4: 267–275.
7. Wachsman JT (1997) DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. Mutat Res 375: 1–8.
8. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358: 1148–1159.
9. Rodriguez-Paredes M, Esteller M (2011) Cancer epigenetics reaches mainstream oncology. Nat Med 17: 330–339.
10. Wilson AS, Power BE, Molloy PL (2007) DNA hypomethylation and human diseases. Biochim Biophys Acta 1775: 138–162.
11. Hatziapostolou M, Iliopoulos D (2011) Epigenetic aberrations during oncogen-esis. Cell Mol Life Sci 68: 1681–1702.
12. Pornthanakasem W, Kongruttanachok N, Phuangphairoj C, Suyarnsestakorn C, Sanghangthum T, et al. (2008) LINE-1 methylation status of endogenous DNA double-strand breaks. Nucleic acids research 36: 3667–3675.
13. Kongruttanachok N, Phuangphairoj C, Thongnak A, Ponyeam W, Rattanatanyong P, et al. (2010) Replication independent DNA double-strand break retention may prevent genomic instability. Molecular cancer 9: 70.
14. Aporntewan C, Phokaew C, Piriyapongsa J, Ngamphiw C, Ittiwut C, et al. (2011) Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2. PloS one 6: e17934.
15. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, et al. (2004) Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23: 8841–8846.
16. Kitkumthorn N, Mutirangura A (2011) Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications. Clin Epigenet doi:10.1007/s13148-13011-10032-13148.
17. Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA (1999) DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 80: 1312–1321.
18. Jurgens B, Schmitz-Drager BJ, Schulz WA (1996) Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res 56: 5698–5703.
19. Choi SH, Worswick S, Byun HM, Shear T, Soussa JC, et al. (2009) Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer. Int J Cancer 125: 723–729.
20. Moore LE, Pfeiffer RM, Poscablo C, Real FX, Kogevinas M, et al. (2008) Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol 9: 359–366.
21. Wilhelm CS, Kelsey KT, Butler R, Plaza S, Gagne L, et al. (2010) Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res 16: 1682–1689.
22. Cash HL, Tao L, Yuan JM, Marsit CJ, Houseman EA, et al. (2012) LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int J Cancer 130: 1151–1159.
23. Phokaew C, Kowudtitham S, Subbalekha K, Shuangshoti S, Mutirangura A (2008) LINE-1 methylation patterns of different loci in normal and cancerous cells. Nucleic acids research 36: 5704–5712.
24. Baba Y, Huttenhower C, Nosho K, Tanaka N, Shima K, et al. (2010) Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Molecular cancer 9: 125.
25. Singer H, Walier M, Nusgen N, Meesters C, Schreiner F, et al. (2012) Methylation of L1Hs promoters is lower on the inactive X, has a tendency of being higher on autosomes in smaller genomes and shows inter-individual variability at some loci. Human molecular genetics 21: 219–235.
26. Pobsook T, Subbalekha K, Sannikorn P, Mutirangura A (2011) Improved measurement of LINE-1 sequence methylation for cancer detection. Clin Chim Acta 412: 314–321.
27. Faul F, Erdfelder E, Buchner A, Lang AG (2009) Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behavior research methods 41: 1149–1160.
28. Kitkumthorn N, Tuangsintanakul T, Rattanatanyong P, Tiwawech D, Mutirangura A LINE-1 methylation in the peripheral blood mononuclear cells of cancer patients. Clin Chim Acta. 2012 Feb 1. http://dx.doi.org/10.1016/j.cca.2012.01.024.
29. Castegna A, Drake J, Pocernich C, Butterfield DA (2003) Protein Carbonyl Levels—An Assessment of Protein Oxidation. Methods in Biological Oxidative Stress. In: Hensley K, Floyd RA, editors: Humana Press. pp 161–168.
30. Nelson HH, Marsit CJ, Kelsey KT (2011) Global methylation in exposure biology and translational medical science. Environmental health perspectives 119: 1528–1533.
31. Franco R, Schoneveld O, Georgakilas AG, Panayiotidis MI (2008) Oxidative stress, DNA methylation and carcinogenesis. Cancer Lett 266: 6–11.
32. Campos AC, Molognoni F, Melo FH, Galdieri LC, Carneiro CR, et al. (2007) Oxidative stress modulates DNA methylation during melanocyte anchorage blockade associated with malignant transformation. Neoplasia 9: 1111–1121.
33. Hartnett L, Egan LJ (2012) Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis.
34. Weitzman SA, Turk PW, Milkowski DH, Kozlowski K (1994) Free radical adducts induce alterations in DNA cytosine methylation. Proceedings of the National Academy of Sciences of the United States of America 91: 1261–1264.
35. Kuchino Y, Mori F, Kasai H, Inoue H, Iwai S, et al. (1987) Misreading of DNA templates containing 8-hydroxydeoxyguanosine at the modified base and at adjacent residues. Nature 327: 77–79.
36. Hitchler MJ, Domann FE (2007) An epigenetic perspective on the free radical theory of development. Free radical biology & medicine 43: 1023–1036.
37. Lertratanangkoon K, Orkiszewski RS, Scimeca JM (1996) Methyl-donor deficiency due to chemically induced glutathione depletion. Cancer research 56: 995–1005.
38. Lertratanangkoon K, Wu CJ, Savaraj N, Thomas ML (1997) Alterations of DNA methylation by glutathione depletion. Cancer letters 120: 149–156.
39. Miller JW, Borowsky AD, Marple TC, McGoldrick ET, Dillard-Telm L, et al. (2008) Folate, DNA methylation, and mouse models of breast tumorigenesis. Nutrition reviews 66 Suppl 1: S59–64.
40. Miller JW, Nadeau MR, Smith J, Smith D, Selhub J (1994) Folate-deficiency-induced homocysteinaemia in rats: disruption of S-adenosylmethionine’s coordinate regulation of homocysteine metabolism. The Biochemical journal 298 (Pt 2): 415–419.
41. Subbalekha K, Pimkhaokham A, Pavasant P, Chindavijak S, Phokaew C, et al. (2009) Detection of LINE-1s hypomethylation in oral rinses of oral squamous cell carcinoma patients. Oral oncology 45: 184–191.
42. Yilmaz IA, Akcay T, Cakatay U, Telci A, Ataus S, et al. (2003) Relation between bladder cancer and protein oxidation. Int Urol Nephrol 35: 345–350.
43. Badjatia N, Satyam A, Singh P, Seth A, Sharma A (2010) Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urol Oncol 28: 360–367.
44. Bartosz G (2003) Total antioxidant capacity. Advances in clinical chemistry 37: 219–292.
45. Dey P (2004) Urinary markers of bladder carcinoma. Clinica chimica acta; international journal of clinical chemistry 340: 57–65.
46. Vrooman OP, Witjes JA (2008) Urinary markers in bladder cancer. European urology 53: 909–916.
47. Mitra AP, Cote RJ (2010) Molecular screening for bladder cancer: progress and potential. Nat Rev Urol 7: 11–20.
48. Van Tilborg AA, Bangma CH, Zwarthoff EC (2009) Bladder cancer biomarkers and their role in surveillance and screening. International journal of urology: official journal of the Japanese Urological Association 16: 23–30.